ARTICLE | Clinical News
Second generation antisense chemistries regulatory update
April 8, 2002 7:00 AM UTC
The University of Massachusetts (Worcester, Mass.) received U.S. Patent No. 6,346,614 covering antisense oligonucleotides comprising a deoxyribonucleotide, a 2'-substituted ribonucleotide and a phosph...